WHO WE ARE

Aprea Therapeutics is a privately held, clinical-stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53.

Explore Partnership Opportunities

3box_1APR-246

Strong synergy with other anticancer drugs

Learn More

cad_greenp53

Tumor suppressor and key to cancer treatment

Learn More

news_blueLatest News

Aprea Therapeutics presenting at the 7th International Mutant p53 Workshop

Learn More